Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development

The invention enables a test to better understand age-dependent chronic diseases that involve pathological inflammatory responses. The inventors demonstrated that a somatic mutation in hematopoietic cells will promote cardio-metabolic diseases. Because somatic mutations in hematopoietic cells are common in the aging human population, these data provide avenues for new genetic tests to determine the risk of developing cardiovascular disease and they suggest new strategies for the treatment and prevention of cardiometabolic diseases. Thomas J McMurry 617-358-4550

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More